Table 2.
Unadjusted | Adjusted I | Adjusted II | |
---|---|---|---|
HR (95% CI) | HR (95% CI) | HR (95% CI) | |
Mild liver dysfunction | No. M = 1409 | No. M = 1409 | No. M = 1409 |
1.44 (1.12, 1.84)* | 1.56 (1.20, 2.03)* | 1.36 (1.01, 1.82)* | |
Moderate liver dysfunction | No. M = 1382 | No. M = 1382 | No. M = 1382 |
1.50 (1.16, 1.96)* | 1.63 (1.24, 2.16)* | 1.37 (1.01, 1.85)* | |
Severe liver dysfunction | No. M = 1239 | No. M = 1239 | No. M = 1239 |
1.37 (0.89, 2.12) | 1.60 (1.01, 2.54)* | 1.72 (1.02, 2.90)* |
Unadjusted: unadjusted for any covariables.
Adjusted I: adjusted for age, sex, and body mass index (BMI) on admission.
Adjusted II: adjusted for fixed covariates including age, sex, body mass index (BMI), SBP, smoking, alcohol, highest temperature, chest congestion, liver cirrhosis, HBV, and clinical classification on admission, and time-varied covariates including white blood cell count (WBC), rapid C-reactive protein (RCP), serum amyloid A protein (SAA), alkaline phosphatase (ALP), activated partial thromboplastin time (APTT), glomerular filtration rate (GFR), lipoprotein A (LppA), hemoglobin (Hb), sodium concentration, actual base excess (ABE), and anion gap (AG) during the lateral observation period.
LLCNH, low lymphocyte ratio complicated with high neutrophil ratio (lymphocyte ratio ≤26.1 and neutrophil ratio ≥62.0); HR, hazard ratio; CI, confidence interval; No. M, the number of measurements.
*The incidence of liver dysfunction in the LLCHN group was significantly different compared to the normal group.